MSMariko Sekimizu

Mariko Sekimizu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mariko Sekimizu has a total of 32 co-authors. Here are the top co-authors by number of shared publications:

  • Hiroyuki Ozawa

    Department of Otolaryngology and Head and Neck Surgery, Keio University School of Medicine , 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582

    4 shared publications
  • Takuya Mikoshiba

    Department of Otolaryngology and Head and Neck Surgery, Keio University School of Medicine , 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582

    4 shared publications
  • Ryoto Nagai

    Department of Otolaryngology, Head and Neck Surgery, Keio University School of Medicine , 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582

    3 shared publications
  • Shintaro Nakamura

    Department of Otolaryngology, Head and Neck Surgery, Keio University School of Medicine, Shinjuku-ku, Japan

    3 shared publications
  • Fumihiro Ito

    Department of Otolaryngology, National Hospital Organization Tokyo Medical Center, Meguro-ku, Japan

    2 shared publications
  • Hiroyuki Ozawa

    Department of Otorhinolaryngology, Head and Neck Surgery, Keio University School of Medicine, Tokyo, Japan

    2 shared publications

Latest Publications

  • Open Access

    Prognostic impact of MRI-based cervical skeletal muscle mass on survival in parotid gland carcinoma

    by Ken Kasahara, Takuya Mikoshiba, Katsuyoshi Idei, Yuki Matsui, Takeyuki Kono, Mariko Sekimizu, Hiroyuki Ozawa

    Background: Parotid gland carcinoma (PGC) is rare and prognostic evidence is limited, making preoperative risk stratification challenging. We evaluated the prognostic relevance of pretreatment skeletal muscle mass measured on routine cervical magnetic resonance imaging. Methods: We retrospectively analyzed 58 patients with histopathologically confirmed PGC treated between 1991 and 2024. Cervical skeletal muscle mass was quantified as the C3 skeletal muscle index (C3SMI) using axial T2-weighted magnetic resonance imaging (MRI) at the C3 level. Overall survival (OS) and recurrence-free survival (RFS) were assessed using Kaplan–Meier analysis and Cox proportional hazards models. Results: Low C3SMI was significantly associated with worse OS and RFS on Kaplan–Meier analysis. In multivariable Cox models restricted to pretreatment variables, low C3SMI remained an independent predictor of shorter OS and RFS. In addition, low C3SMI was significantly associated with adverse pathological features, including high-grade histology, perineural invasion, extracapsular extension, and lymphovascular invasion. Conclusions: MRI-derived C3SMI is an independent prognostic biomarker for survival and recurrence in PGC and correlates with pathological aggressiveness. Because C3SMI can be obtained from standard preoperative cervical MRI without additional imaging or radiation exposure, it may provide a practical tool for preoperative risk stratification and treatment planning in patients with PGC.

  • Open Access

    Nationwide analysis of olfactory neuroblastoma in Japan: evolving treatment approaches and prognostic outcomes

    by Mariko Sekimizu, Takuya Mikoshiba, Ryoto Nagai, Naoaki Ishikawa, Takashi Okada, Megumi Kitayama, Daisuke Kawakita, Ken-Ichi Nibu, Seiichi Yoshimoto, Hiroyuki Ozawa

    Background: Olfactory neuroblastoma (ONB) is a rare malignant tumor of the nasal cavity and paranasal sinuses. In this study, we aimed to analyze ONB cases registered in the nationwide Head and Neck Cancer Registry of Japan. Methods: Among 90 885 head and neck cancer registrations (2011–19), we identified 346 patients with ONB. We summarized demographics, tumor-node-metastasis (TNM) classification, and treatment modalities (surgery, radiotherapy, chemotherapy) and compared patterns between an early (2011–15) and a late (2016–19) period. Survival was analyzed in 95 patients with standardized 5-year outcomes available. Results: T4 lesions were frequent, and 234 patients (67.6%) received surgery-based treatment, typically combined with postoperative radiotherapy. Over time, endoscopic approaches increased markedly and became predominant over open skull base surgery. Among the 95 patients with evaluable follow-up, the 5-year overall survival (OS) and 5-year recurrence-free survival (RFS) were 85.1% and 62.7%, respectively. Patients <60 years old and female patients exhibited better OS compared to younger patients and males. Postoperative radiotherapy was associated with improved RFS but not OS. Chemotherapy was used more often with open skull base surgery than with other surgical approaches. Conclusions: Endoscopic surgery for ONB rose substantially, while younger age and female sex were associated with better OS, and postoperative radiotherapy was correlated with improved RFS.

  • Open Access

    Nationwide Analysis of Olfactory Neuroblastoma in Japan: Evolving Treatment Approaches and Prognostic Outcomes

    by Mariko Sekimizu, Takuya Mikoshiba, Ryoto Nagai, Naoaki Ishikawa, Takashi Okada, Megumi Kitayama, Daisuke Kawakita, Ken-Ichi Nibu, Seiichi Yoshimoto, Hiroyuki Ozawa

    Background: Olfactory neuroblastoma (ONB) is a rare and malignant tumor of the nasal cavity. This study aimed to analyze cases of ONB from the Head and Neck Cancer Registry of Japan. Methods: We identified 346 patients with ONB from 90,885 head and neck cancer registrations between 2011 and 2019. Data on demographics, TNM stage, and treatment modalities (surgery, radiotherapy, and chemotherapy) were collected. Patients were divided into early (2011–2015) and late (2016–2019) groups to assess changes in treatment patterns. Survival was analyzed in 95 patients with available follow-up data. Results: T4 lesions were frequently observed, and 234 patients (67.6%) underwent surgery-based treatment, typically combined with radiotherapy. Over time, the use of endoscopic approaches increased significantly, replacing open cranial base surgery. Among the 95 patients with evaluable follow-up data, the 5-year overall survival (OS) rate was 85.1%, while the recurrence-free survival (RFS) rate was 62.7%. Patients younger than 60 years and female patients had improved OS. Postoperative radiotherapy improved RFS but did not impact OS. Chemotherapy was frequently used in cases requiring extensive cranial base resections. Conclusions: This large-scale, multicenter study provides insight into ONB treatment trends and outcomes in Japan. Although the 5-year prognosis is favorable, a significant risk of recurrence remains, emphasizing the need for optimized long-term treatment strategies. The widespread adoption of endoscopic surgery suggests shift toward less invasive approaches. Further prospective studies are needed to refine therapeutic options and improve long-term outcomes for patients with ONB.

  • Open Access

    Carotid body tumor with neck metastasis due to germline SDHB variant: a case report and literature review

    by Takuya Mikoshiba, Keisuke Yoshihama, Fumihiro Ito, Mariko Sekimizu, Shintaro Nakamura, Ryoto Nagai, Takenori Akiyama, Kentaro Matsubara, Hideaki Obara, Hiroyuki Ozawa

    Carotid body tumor involving the succinate dehydrogenase subunit B (SDHB) variant reportedly had a higher frequency of metastasis than other variants of succinate dehydrogenase. However, the correlation between genotype and phenotype among patients with carotid body tumor with SDHB gene variant remains unclear. Thus, we present a case of carotid body tumor with neck lymph metastasis caused by a novel SDHB variant, which resulted in long-term disease-free survival achieved after surgery. A 43-year-old man presented to our hospital with a 2-year history of a painless neck mass. Based on the radiographic findings, the patient was diagnosed with carotid body tumor with a possible Shamblin type III tumor. Another mass was detected and suspected to be a lymph node metastasis. The patient underwent resection of the tumor and lymph nodes. The common carotid artery, internal carotid artery, external carotid artery, internal jugular vein, vagal nerve, and hypoglossal nerve were resected with the tumor. Histopathological examination revealed a paraganglioma. The histological findings of the lymph nodes were similar to those of the carotid body tumor and were confirmed to be metastases of paraganglioma. To analyze the germline SDHx variant, a nonsense variant was detected in the SDHB gene at exon 2, c. 136C > T, p. Arg46*. During the follow-up 80 months after surgery, the patient exhibited no signs of recurrence, metastasis, or development of paragangliomas in other organs. This was the first case of carotid body tumor accompanied by neck metastasis caused by a germline nonsense SDHB variant at exon 2, c. 136C > T, p. Arg46*. Carotid body tumor with neck lymph metastasis caused by this nonsense variant could achieve long-term disease-free survival after surgery. Gene analysis, including SDHB variant, should be performed to predict the prognosis and future risk of metastasis. Genetic testing of SDHB may give a crucial information for the treatment and follow-up strategies of carotid body tumor.


  • Endoscopic Endonasal Management of Pterygopalatine Fossa Tumors

    by Hiroyuki Ozawa, Mariko Sekimizu, Shin Saito, Shintaro Nakamura, Takuya Mikoshiba, Masahiro Toda, Kaoru Ogawa

    Surgical removal of pterygopalatine fossa (PPF) tumors with endoscopic endonasal approach is still challenging. The present study aimed to evaluate our endoscopic endonasal management of PPF tumors based on the tumor pathology and purpose of the surgery. This comprised both a single nostril approach for biopsy and a binostril approach for complete resection of benign and noninfiltrating tumors. Based on this strategy, 12 patients underwent endoscopic endonasal surgery for PPF tumors between 2013 and 2018. The patients’ data were analyzed retrospectively to demonstrate the significance of our treatment scheme. The surgery was terminated only after taking a biopsy specimen in 6 patients. Other 6 patients underwent gross total resection or bulk tumor reduction. Final pathological diagnosis was malignant in 6 cases and benign in the remaining 6. Post-operative treatment was needed in 7 patients. Four operations for the 6 patients who underwent either debulking or radical surgery were performed by the binostril approach; while 5 surgeries for the 6 biopsy patients were performed by the single nostril approach. Postoperative complications were tolerable. Endoscopic resection should be adopted preferentially for benign tumors that can be removed in a piecemeal fashion. However, as most malignant tumors were impossible to resect with a negative margin, priority should be given to tumor biopsy using an endoscopic approach, which is less invasive than an open approach, and an appropriate treatment customized to the pathological diagnosis should be administered.


  • Open Access

    Cyclo-oxygenase-2 Expression Is Associated With Lymph Node Metastasis in Oropharyngeal Squamous Cell Carcinoma Under the New TNM Classification

    by Mariko Sekimizu, Hiroyuki Ozawa, Shin Saito, Yuichi Ikari, Nana Nakahara, Shintaro Nakamura, Keisuke Yoshihama, Fumihiro Ito, Yoshihiro Watanabe, Yorihisa Imanishi, et al.

    Background: This study aimed to investigate p16 and COX2 expression in oropharyngeal squamous cell carcinoma (OPSCC), and evaluate the prognostic role of COX2 expression under the new TNM classification. Materials and Methods: Biopsy specimens obtained from 75 patients with OPSCC were stained for p16 and COX2 expression immunohistochemically. The results and clinical records were analyzed retrospectively. Results: Fifty-nine patients (79%) were positive for p16. COX2 expression was correlated with poor relapse-free survival in patients overall, and in p16-positive patients. Smoking was positively associated with COX2 expression. Moreover, both positive COX2 expression and anterior wall tumor subsite were independently correlated with lymph node metastasis, which was the only independent prognostic factor in p16-positive OPSCC. Conclusion: The p16-positive rate in this study was comparable with that in the USA and Europe, and higher than that in other Asian countries. COX2 expression might affect the prognosis of p16-positive OPSCC through promoting lymph node metastasis.